ZBIO

ProShares UltraPro Short NASDAQ Biotechnology
ZBIO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ZBIO was delisted on the 27th of March, 2020.

Back to rankings

6 hedge funds and large institutions have $896K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$252K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$479K
2
+$17K
3
+$3K
4
CG
Cutler Group
California
+$129

Top Sellers

1
-$213K
2
-$42.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$479K
2
$204K
3
$180K
4
$17K
5
$13K
6
$3K